HCPLive

Related Tags

Cell-Cycle Progression Panel Identifies Prostate Cancer Risk

THURSDAY, March 28 (HealthDay News) -- The cell-cycle progression (CCP) gene panel is useful to improve the risk stratification for men with even low-risk, clinically localized prostate cancer, according to research published online March 4 in the Journal of Clinical Oncology.

Matthew R. Cooperberg, MD, MPH, of the University of California in San Francisco, and colleagues sought to validate a previously described genetic risk score called CCP (that provides a value calculated from the average expression of 31 CCP genes) and its ability to improve risk stratification in men with localized prostate cancer and predict recurrence after prostatectomy.

The researchers found that for each increase of one unit in the CCP score, the hazard ratio increased by 1.7, after adjusting for the patient's Cancer of the Prostate Risk Assessment Post-Surgical (CAPRA-S) score. Combining the CCP with the CAPRA-S score yielded consistently predictive outcomes across a range of clinical risk, including low-risk patients.

"The performance of the CCP score in this validation study was excellent," the authors write. "The score provided independent prognostic information after radical prostatectomy and may prove useful in helping guide decisions with respect to adjuvant treatment and in stratifying men for future adjuvant therapy studies."

Several authors disclosed financial ties to genetics firms. Myriad Genetics helped support the study.

Abstract
Full Text (subscription or payment may be required)

Most Popular

Recommended Reading

One of the most important things for many patients with multiple sclerosis is their ability to be able to move on their own despite the condition. Sometimes the reasons they are unable to move the way they want may go beyond the original diagnosis.
In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.
Proper nutrition can benefit everyone but keeping a healthy diet can be especially important for patients with multiple sclerosis.
While it is a rare condition and no medications have been approved for its treatment patients with neuromyelitis optica can get the help they need if doctors know what they are looking for.
$vAR$